https://www.avient.com/sites/default/files/2022-06/MEVOPUR Bio-based Solutions Application Bulletin_CN %281%29.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:(1) 接触人体组织或体液长达30天或更长时间; (2)“整形”(整容或重建)手术; (3) 生殖植入物或任何节育器械;或者 (4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2023-04/Fiber Colorants and Additives Brochure.pdf
COMMITMENT TO RECORD RETENTION Formulations and yarn samples of every production lot are archived and retained for 2 to 5 years to ensure traceability.
https://www.avient.com/sites/default/files/2022-08/MEVOPUR Special Effect Colors Application Bulletin_CN.pdf
在不限制本声明的一般性的情况下,不得将埃万特的产品用于旨在用于以下目的的任何医疗器械应用:(1) 接触人体组织或体液长达30天或更长时间; (2)“整形”(整容或重建)手术; (3) 生殖植入物或任何节育器械;或者 (4) 用于支持或维持人类生命的永久性(超过30天)植入式医疗器械中的任何关键组件。
https://www.avient.com/sites/default/files/2024-09/Compensation Committee Charter July 2024.pdf
General Purposes The general purposes of the Committee are to: • Oversee the Company’s overall executive compensation philosophy and objectives; • Discharge the Board’s responsibilities relating to compensation of the Company’s executive officers (for purposes of this Charter, “executive officers” means the Company’s Section 16 “officers” as defined under Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended); • Assist the Board in the discharge of its fiduciary responsibilities with regard to establishment of policies governing, and the implementation of, all aspects of executive officer compensation throughout the Company, including benefits and perquisites, and compensation for any other employees designated by the Committee for such purposes; • Discharge similar responsibilities with respect to the compensation of non-employee directors; • Review and discuss with management the Company’s disclosures in the Compensation Discussion and Analysis (the “CD&A”) required by rules and regulations of the Securities and Exchange Commission (the “SEC”) and recommend to the Board whether the CD&A should be included in the Company’s proxy statement or other applicable SEC filings; • Prepare a Compensation Committee Report for inclusion in the Company’s applicable filings with the SEC that complies with the rules and regulations of the SEC; and • Provide policy guidance and oversight on significant human resource policies and practices. 2 Duties and Responsibilities The Committee will: Executive Compensation and Incentives
https://www.avient.com/sites/default/files/2024-10/Compensation Committee Charter - Final.pdf
Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. 2 • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board (including as described in the Company’s Corporate Governance Guidelines), evaluate the Chief Executive Officer’s performance annually in light of these goals and objectives; and determine and recommend to the independent members of the Board for their determination and approval the Chief Executive Officer’s compensation level based on this evaluation and considering comparable market data provided by an independent compensation consultant
https://www.avient.com/investor-center/news/avient-provides-fourth-quarter-2020-updates
Special items, tax adjustments(2) 2)
https://www.avient.com/center-of-excellence/avient-europe-middle-east-and-africa
2 Rue Melville Wilson, Adolf Dambach-Strasse 2,
https://www.avient.com/sites/default/files/2023-07/Avient_CodeConduct_2023_Hungary.pdf
Magatartási kódexünk 2023 Tartalomjegyzék Üzenet a CEO-tól 1 Víziónk és stratégiánk 2 Alapvető és személyes értékek 2 Magatartási kódexünk Az etikus magatartás irányelvei 4 Személyes értékek 4 Problémamegoldás és a szabálysértések jelentése 6 Etikai forródrót 6 Tilos a megtorlás! Patterson, elnök-vezérigazgató 2 Tartalomjegyzék Víziónk és stratégiánk Jövőkép Az Avientnál speciális és fenntartható anyagmegoldásokat hozunk létre, amelyek az ügyfelek kihívásait lehetőségekké alakítják, és új termékeket hívnak életre egy jobb világ érdekében. Kövesse ezt a két szabályt: 1. 1. ne használjon fel fontos nem nyilvános információkat saját haszonszerzés céljából; és 2. 2. az ilyen információt ne ossza meg olyan személlyel, akinek nem kell feltétlenül tudnia róla az Avient vállalatnál végzett munkájából kifolyólag.
https://www.avient.com/sites/default/files/2021-03/avient-antitrust-2021-update-vi-a4.pdf
Bất cứ khi nào bạn dự kiến tham gia vào các hoạt động nhạy cảm chống độc quyền có thể có ảnh hưởng trong hoặc ngoài Hoa Kỳ, bạn nên tham khảo trước với phòng Pháp chế của Avient. 2 Nội dung Chính sách Chống độc quyền Sửa đổi Năm 2021 Bạn có biết? Từ chối Giao dịch - Thỏa thuận với một đối thủ cạnh tranh để tẩy chay hoặc không giao dịch với một công ty thứ ba. 2. Tránh tiếp xúc không cần thiết với đối thủ cạnh tranh. 2.
https://www.avient.com/investor-center/news/polyone-announces-record-first-quarter-2016-results
Attachment 2 Tax adjustments(2) 2) Tax adjustments include the net tax expense/benefit from one-time income tax items, the set-up or reversal of uncertain tax position reserves and deferred income tax valuation allowance adjustments.